Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Tickner

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Journal of Cellular Physiology|August 28, 2018
Asiaticoside, a component of Centella asiatica attenuates RANKL-induced osteoclastogenesis via NFATc1 and NF-κB signaling pathwaysLilei He, Guoju Hong, Lin Zhou, et al.
Frontiers in Pharmacology|April 16, 2020
Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis <i>Via</i> Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling PathwaysGuoju Hong, Lin Zhou, Xiaorui Han, et al.
Journal of Cellular and Molecular Medicine|October 16, 2019
Asperpyrone A attenuates RANKL-induced osteoclast formation through inhibiting NFATc1, Ca<sup>2+</sup> signalling and oxidative stressXi Chen, Chao Wang, Heng Qiu, et al.
Journal of Cellular Physiology|June 16, 2018
Lumichrome inhibits osteoclastogenesis and bone resorption through suppressing RANKL-induced NFAT activation and calcium signalingChuan Liu, Zhen Cao, Wen Zhang, et al.
Journal of Cellular Physiology|October 21, 2018
Helvolic acid attenuates osteoclast formation and function via suppressing RANKL-induced NFATc1 activationKai Chen, Yu Yuan, Ziyi Wang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 20, 2015
Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling PathwaysLin Zhou, Qian Liu, Mingli Yang, et al.
Journal of Cellular Physiology|November 19, 2016
Mechanical Stress Regulates Bone Metabolism Through MicroRNAsYu Yuan, Lingli Zhang, Xiaoyang Tong, et al.
International Journal of Molecular Sciences|January 21, 2017
Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFATGuoju Hong, Lin Zhou, Xuguang Shi, et al.
Frontiers in Cell and Developmental Biology|June 26, 2020
Conditional Knockout of PKC-δ in Osteoclasts Favors Bone Mass Accrual in Males Due to Decreased Osteoclast FunctionShangfu Li, Tianwei He, Depeng Wu, et al.
Cell Death & Disease|September 17, 2020
PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncouplingShangfu Li, Qiuli Liu, Depeng Wu, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Journal of Cellular Physiology|August 28, 2018
Asiaticoside, a component of Centella asiatica attenuates RANKL-induced osteoclastogenesis via NFATc1 and NF-κB signaling pathwaysLilei He, Guoju Hong, Lin Zhou, et al.
Frontiers in Pharmacology|April 16, 2020
Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis <i>Via</i> Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling PathwaysGuoju Hong, Lin Zhou, Xiaorui Han, et al.
Journal of Cellular and Molecular Medicine|October 16, 2019
Asperpyrone A attenuates RANKL-induced osteoclast formation through inhibiting NFATc1, Ca<sup>2+</sup> signalling and oxidative stressXi Chen, Chao Wang, Heng Qiu, et al.
Journal of Cellular Physiology|June 16, 2018
Lumichrome inhibits osteoclastogenesis and bone resorption through suppressing RANKL-induced NFAT activation and calcium signalingChuan Liu, Zhen Cao, Wen Zhang, et al.
Journal of Cellular Physiology|October 21, 2018
Helvolic acid attenuates osteoclast formation and function via suppressing RANKL-induced NFATc1 activationKai Chen, Yu Yuan, Ziyi Wang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 20, 2015
Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling PathwaysLin Zhou, Qian Liu, Mingli Yang, et al.
Journal of Cellular Physiology|November 19, 2016
Mechanical Stress Regulates Bone Metabolism Through MicroRNAsYu Yuan, Lingli Zhang, Xiaoyang Tong, et al.
International Journal of Molecular Sciences|January 21, 2017
Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFATGuoju Hong, Lin Zhou, Xuguang Shi, et al.
Frontiers in Cell and Developmental Biology|June 26, 2020
Conditional Knockout of PKC-δ in Osteoclasts Favors Bone Mass Accrual in Males Due to Decreased Osteoclast FunctionShangfu Li, Tianwei He, Depeng Wu, et al.
Cell Death & Disease|September 17, 2020
PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncouplingShangfu Li, Qiuli Liu, Depeng Wu, et al.
Pageof 7